ixekizumab - Articles and news items


Lilly presents new data from the UNCOVER-2 trial of ixekizumab

Industry news / 8 March 2016 / Victoria White

In UNCOVER-2, patients with plaque psoriasis who did not respond to etanercept achieved significant improvement in their psoriasis plaques when treated with ixekizumab…

Lilly’s ixekizumab demonstrates efficacy in psoriatic arthritis

Industry news / 10 November 2015 / Victoria White

Psoriatic arthritis patients treated with ixekizumab for 24 weeks achieved significant improvements in signs and symptoms of their disease compared to placebo…


The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...